Barclays’s AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF SIXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-140
Closed -$4.38K 5684
2026
Q1
$4.38K Buy
140
+37
+36% +$1.17K ﹤0.01% 4786
2025
Q4
$3.25K Sell
103
-1,115
-92% -$34.7K ﹤0.01% 5018
2025
Q3
$37.5K Sell
1,218
-3,806
-76% -$114K ﹤0.01% 4836
2025
Q2
$147K Sell
5,024
-160
-3% -$4.46K ﹤0.01% 4466
2025
Q1
$143K Buy
+5,184
New +$145K ﹤0.01% 4251

Other funds holding SIXP

Barclays's SIXP Position: Q2 2026 in Review

Barclays sold out of AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) in Q2 2026, closing a stake of 140 shares — an estimated $4.38K sold.

Barclays first reported a position in SIXP in Q1 2025 and held it in 5 quarters. The position peaked at $147K in Q2 2025. 24 funds tracked by Wall St. Rank hold SIXP as of Q2 2026.

  • Barclays reported no remaining AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 140 AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF shares in Q2 2026, an estimated $4.38K.
  • Barclays first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF in Q1 2025 and held it in 5 quarters.
  • Barclays's AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position peaked at $147K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.